Neurobiological modulation with REAC technology: enhancing pain, depression, anxiety, stress, and quality of life in post-polio syndrome subjects

Neurovegetative dysfunction from chronic stress impairs cognition, emotional regulation, and quality of life, with limited relief from conventional therapies. The Radio Electric Asymmetric Conveyer (REAC) Neuro Psycho Physical Optimization - Brain Wave Optimization-Gamma (NPPO BWO-G) offers a novel non-invasive approach to restore autonomic balance through brain modulation. This case involves a 63-year-old businessman with atrial fibrillation, fatigue, cognitive decline, and sleep issues. Pre-treatment quantitative electroencephalogram (qEEG) showed low brain activity and excess delta rhythms. After REAC NPPO BWO-G sessions, the patient experienced improved brainwave patterns, cognitive clarity, stress management, and reduced fatigue. These results highlight its potential as a promising treatment for stress-related neurovegetative dysfunction, warranting further study.

Efficacy of Radio Electric Asymmetric Conveyer Neuro Psycho Physical Optimization - Brain Wave Optimization-Gamma (REAC NPPO BWO-G) Treatment in Neurovegetative Dysfunction: A Case Report of Enhanced Cognitive Processing and Stress Resilience

Modesto',

Rinaldi,

Fontani

et al. 2024

Therapeutic Outcomes of Biomodulation With Radio Electric Asymmetric Conveyer (REAC) Technology in an 80-Year-Old Female: A Case Report on Anti-cellulite, Circulatory, and Metabolic Optimization Treatments

Higino Rocha,

Fontani,

Rinaldi

2024

This case report examines the therapeutic outcomes of Radio Electric Asymmetric Conveyer (REAC) anti-cellulite treatment (ACT), circulatory optimization (CO), and metabolic optimization (MO) in an 80-year-old female with multiple chronic conditions, including morbid obesity, type 2 diabetes mellitus, hypertension, and a history of deep vein thrombosis. Each treatment protocol was administered in 18-session cycles. The patient experienced substantial improvements in edema, erythema, pain, and mobility, with a reduced reliance on analgesics. Moreover, there were significant enhancements in sleep quality, mood, mental clarity, and a 7-kg weight loss. These results suggest that REAC ACT, CO, and MO treatments effectively addressed not only localized symptoms but also contributed to broader systemic health improvements by promoting cellular homeostasis and energy production. This case highlights the potential of these REAC treatments as non-invasive and effective options for elderly patients with complex health profiles, encouraging further studies to establish standardized treatment protocols.

Efficacy of Radio Electric Asymmetric Conveyor (REAC) Anti-inflammatory, Circulatory, and Metabolic Optimization Treatments for Managing Chronic Pain, Edema, and Lipodystrophy in Post-menopausal Women: A Case Series

Higino Rocha,

Covallero Renck,

Fontani

et al. 2024

Chronic pain, edema, and lipodystrophy are common issues in post-menopausal women, often linked to hormonal imbalances, metabolic dysfunctions, and chronic inflammation. Traditional treatments, such as hormone replacement therapy (HRT) and aesthetic procedures, frequently provide limited and temporary relief. This case series evaluates the effectiveness of radio electric asymmetric conveyor (REAC) technology specifically, the anti-cellulite treatment (ACT), circulatory optimization (CO), and metabolic optimization (MO) protocols in four post-menopausal women presenting with these conditions. Each patient underwent 18 sessions of ACT, CO, and MO protocols using the REAC Bio-Enhancer Neuro-Enhancer (BENE) 110 medical device (ASMED Srl, Scandicci Florence, Italy), with asymmetric conveyor probes (ACPs) symmetrically positioned on the quadriceps. The ACT protocol targeted skin and subcutaneous tissue biomechanical properties, the CO protocol focused on enhancing circulation and reducing edema, and the MO protocol aimed to restore metabolic balance. The results demonstrated significant improvements across all patients, with reductions in pain (9/10 to 3/10), edema, and lipodystrophy, as well as enhanced mood and overall well-being. Objective measures, such as reductions in thigh circumference and improvements in inflammatory markers, further supported the systemic benefits of REAC ACT, CO, and MO treatments. These findings suggest that REAC protocols offer a comprehensive and effective non-invasive treatment for chronic inflammatory and metabolic conditions in post-menopausal women.